--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About TENX20261016C2.5
Chemical and pharmaceutical
Tenax Therapeutics, Inc., originally incorporated as a New Jersey corporation in 1967 under the name Rudmer, David & Associates, Inc., was subsequently renamed Synthetic Blood International, Inc. Effective June 30, 2008, the Company changed its registered seat to Delaware and changed its name to Oxygen Biotherapeutics, Inc. On September 19, 2014, the company changed its name to Tenax Therapeutics, Inc. The Company is a specialty pharmaceutical company focused on identifying, developing and commercializing products to address cardiovascular and pulmonary diseases with unmet medical needs. The company's primary business objective is to identify, develop and commercialize novel therapeutic products for disease indications in important areas representing clinical needs and business opportunities.
